Home Dosing Information Order Samples Contact us

Click a link below to be brought to that page in the Mircette® website.


Mircette® Home Page

Clinician Brochure

Dosing Information

Prescribing Information

Order Samples

Contact Us

Terms of Use

Privacy Policy





  THIS INFORMATION IS INTENDED FOR HEALTH CARE PROFESSIONALS ONLY
 

Each package contains 21 tablets of 0.15 mg desogestrel and 20 mcg ethinyl estradiol (EE), 2 placebo tablets, and 5 tablets of 10 mcg EE.

Mircette® tablets are indicated for the prevention of pregnancy.

SAFETY INFORMATION

Serious as well as minor side effects can occur with oral contraceptives. Serious risks include myocardial infarction, thromboembolism, stroke, hepatic neoplasia and gallbladder disease. Cigarette smoking increases the risk of serious cardiovascular side effects; women who take oral contraceptives are strongly advised not to smoke. The risk of morbidity and mortality increases significantly in the presence of other underlying risk factors such as hypertension, hyperlipidemias, obesity and diabetes. Oral contraceptives do not protect against HIV infection (AIDS) and other sexually transmitted infections.

 
 

© 2007 Duramed Pharmaceuticals, Inc. All rights reserved.

Mircette® and Duramed® are registered trademarks of Duramed Pharmaceuticals, Inc.
Duramed is a subsidiary of Barr Pharmaceuticals, Inc.
The site is intended for residents of the United States only.

 

Home   |    Send This Page    |    Contact Us   |    Prescribing Information   |    Terms of Use    |    Privacy Policy    |    Site Map